Lidocaine patches are a form of local anesthetic that people may use to treat areas of pain on their body. The medication in the patches has a numbing effect on the nerves that send pain signals to ...

SAN JOSE, Calif., May 30, 2024 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that the NMPA (National Medical Products Administration) has approved Lidoderm® ("lidocaine 5% patch as ...

Scilex is initiating a legal case against Apotex to protect its lidocaine patch from a potential competitor. According to reports, when the blank-check company Vickers Vantage Corp agreed to merge ...

With four settlement agreements, the state of California will get nearly $70 million from pharmaceutical companies that allegedly cut illegal deals to keep affordable generic drugs off the market, ...

SAN FRANCISCO (CN) - A federal judge on Thursday finalized two class action settlements worth $270 million, ending four years of litigation over an alleged antitrust conspiracy to keep a generic form ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Teikoku Pharma USA Inc. (“TPU”) today announced that it has entered into an exclusive license agreement with Link Health Group LTD (“Link Health”) to develop market, ...

A sell-the-news 24% drop. Oh my! FDA approvals are supposed to make companies worth more, not less, but this seems to simply be a case of "sell the news," given the massive run-up shares of Sorrento ...

As post-Actavis antitrust litigation over so-called “reverse payment” patent settlements proceeds, courts continue to provide further illumination about what evidence a private plaintiff would need to ...

The US District Court for the Northern District of California certified classes of direct purchasers and end-payers in a pay-for-delay multidistrict litigation involving Lidoderm. In re Lidoderm ...